The quality of warfarin prescribing and monitoring in veterans affairs nursing homes

Journal of the American Geriatrics Society

Volumn 58, Issue 8, 2010, Pages 1475-1480

  Aspinall, Sherrie L ^a,b,c   Zhao, Xinhua ^a,b   Handler, Steven M ^b,d   Stone, Roslyn A ^b,e   Kosmoski, Janine C ^f   Libby, Elizabeth A ^g   Francis, Susan Dove ^f   Goodman, David A ^b   Roman, Rebecca D ^b   Bieber, Heather L ^h   Voisine, Jennifer M ⁱ   Jeffery, Sean M ⁱ   Hepfinger, Charley A ^g   Hagen, Diane G ^g   Martin, Micki M ^g   Hanlon, Joseph T ^b,c,d  

^a Veterans Affairs Center for Medication Safety   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

^g Phoenix Veterans Affairs Health Care System   (United States)

^h Pharmacy Department   (United States)

ⁱ VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

healthcare quality assurance; nursing homes; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CITALOPRAM; LEVOTHYROXINE; OMEPRAZOLE; SIMVASTATIN; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; DEEP VEIN THROMBOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PATIENT MONITORING; PRESCRIPTION; QUALITY OF NURSING CARE; SIDE EFFECT; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME; VETERAN;

AGED; ANTICOAGULANTS; COHORT STUDIES; DRUG MONITORING; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; NURSING HOMES; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; STROKE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; WARFARIN;

EID: 77955258963     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02967.x     Document Type: Article

References (26)

1. Gurwitz JH, Field TS, Radford MJ et al. The safety of warfarin therapy in the nursing home setting. Am J Med 2007 120 : 539 544.
2. Verhovsek M, Motlagh B, Crowther MA et al. Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review. BMC Geriatr 2008 8 : 13 18.
3. Gurwitz JH, Field TS, Avorn J et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000 109 : 87 94.
4. McCormick D, Gurwitz JH, Goldberg RJ et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 2001 161 : 2458 2463.
5. Go AS, Fang MC, Chang Y et al. Abstract 3590: Defining a threshold of anticoagulation quality that leads to net clinical benefit in atrial fibrillation: The ATRIA study. Circulation 2007 116 (16 suppl) : II-813.
6. Morgan CL, McEwan P, Tikiendorf A et al. Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control. Thromb Res 2009 124 : 37 41.
7. Jones M, McEwan P, Morgan CL et al. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: A record linkage study in a large British population. Heart 2005 91 : 472 477.
8. Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 2000 9 : 283 292.
9. Lapane KL, Hughes CM. Which organizational characteristics are associated with increased management of depression using antidepressants in US nursing homes? Med Care 2004 42 : 992 1000.
10. Rochon PA, Stukel TA, Bronskill SE et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007 167 : 676 683.
11. Castle NG, Hanlon JT, Handler SM. Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. Am J Geriatr Pharmacother 2009 7 : 143 150.
12. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998 105 : 91 99.
13. Holbrook AM, Pereira JA, Labiris R et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005 165 : 1095 1106.
14. Ansell J, Hirsh J, Hylek E et al. Pharmacology and management of the vitamin K antagonists. Chest 2008 133 : 160S 198S.
15. Handler SM, Shirts BH, Perera S et al. Frequency of laboratory monitoring of chronic medications administered to nursing facility residents: Results of a national Internet-based study. Consult Pharm 2008 23 : 387 395.
16. Fang MC, Chang Y, Hylek EM et al. Advanced age, anticoagulatin intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004 141 : 745 752.
17. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Throm Haemostasis 2005 3 : 692 694.
18. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 30 : 239 245. (Pubitemid 12149145)
19. Kaiser RM, Schmader KE, Pieper CF et al. Therapeutic failure-related hospitalisations in the frail elderly. Drugs Aging 2006 23 : 579 586.
20. Rosendaal FR, Cannegieter SC, van der Meer FJ et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993 63 : 236 239.
21. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York : John Wiley & Sons, 2000.
22. Oake N, Fergusson DA, Forster AJ et al. Frequency of adverse events in patients with poor anticoagulation: A meta-analysis. Can Med Assoc J 2007 176 : 1589 1594.
23. Singer DE, Albers GW, Dalen JE et al. Antithrombotic therapy in atrial fibrillation. Chest 2008 133 : 546S 592S.
24. Rose AJ, Ozonoff A, Berlowitz DR et al. Warfarin dose management affects INR control. J Thromb Haemostasis 2009 7 : 94 101.
25. Dolan G, Smith LA, Collins S et al. Effect of setting, monitoring intensity and patient experience on anticoagulation control: A systematic review and meta-analysis of the literature. Curr Med Res Opin 2008 24 : 1459 1472.
26. Seto AC, Kenyon K, Wittkowsky AK. Discrepancies in identification of major bleeding events in patients taking warfarin. Pharmacotherapy 2008 28 : 1098 1103.